Abstract:Human embryo lung cellular protein interacting with severe acute respiratory syndrome‐coronavirus nonstruc‐ tural protein‐10 (HEPIS) is a novel transcriptional repressor, the expression profile and promoter activity of which have not been well studied. In the present study, in situ hybridization of RNA was used to study differential HEPIS expression levels in different types of cancer and normal tissues. A total of six truncated lengths of the HEPIS promoter regulatory sequences were cloned into the pGL3‐basic vector, and reverse transcrip‐ tion‐quantitative polymerase chain reaction (RT‐qPCR) and dual luciferase reporter assays were performed. The results of RT‐qPCR demonstrated that HEPIS expression levels differed across four breast cancer cell lines. The results of the dual lucif‐ erase reporter assays revealed that the activities of the reporter gene fragments spanning ‐1334/+373, ‐1203/+373, ‐1060/+373 and ‐899/+373 bp were higher compared with the reporter gene fragments spanning ‐759/+373 and ‐279/+373 bp. A search of the transcription factor database TRANSFAC identi‐ fied numerous octamer transcription factor‐1 (OCT‐1), nuclear factor (NF)‐κB and C‐JUN transcription factor binding sites located on the HEPIS promoter (pHEPIS). Furthermore, the results revealed that mutations of the OCT‐1 (‐1236/‐1223 bp), NF‐κB (‐1186/‐1176 bp) and C‐JUN (‐856/‐846 bp) sites on the human pHEPIS resulted in a decrease in luciferase activity. A chromatin immunoprecipitation assay revealed that OCT‐1, NF‐κB and C‐JUN bound to pHEPIS in a site‐dependent manner at the basal state. The TRANSFAC database was used to analyze the pHEPIS of multiple species and several acti‐ vator protein‐1, NF‐κB and OCT‐1 transcription factor binding sites were predicted. In conclusion, the results of the present study suggest that HEPIS is expressed at different levels in multiple organs and breast cancer cell lines. Furthermore, these findings indicate that OCT‐1, NF‐κB and C‐JUN tran‐ scription factors are associated with transcriptional regulation of the HEPIS gene.

Isolation of an ERβ interaction protein HPIP and its role in ERβ singnaling

The Estrogen Receptor-Interacting Protein HPIP Increases Estrogen-Responsive Gene Expression Through Activation of MAPK and AKT.

Isolation of an ERβ-interacting Protein PSMC5 and Its Role in ERβ Signaling

The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT

Isolation and analysis of a novel co-regulator of estrogen receptor beta

Screening of Proteins Interacting with Hprb by Yeast Two Hybrid

Isolation and Characterization of Proteins Interacting with Estrogen Receptor Β

Identification of A Novel Estrogen Receptor Beta 1 Binding Partner, Inhibitor of Differentiation-1, and Role of Er Beta 1 in Human Breast Cancer Cells

Expression and Role of HEPIS in Breast Cancer

The expressing signification of estrogen receptorβ in breast cancer

A Variant of Estrogen Receptor-Alpha, Her-Alpha 36: Transduction of Estrogen- and Antiestrogen-Dependent Membrane-Initiated Mitogenic Signaling

High-Throughput Cell-Based Screening Reveals A Role for Znf131 As A Repressor of Eralpha Signaling

Eukaryotic Expression Vectors Construction and Transcriptional Ac tivity Analysis of Different Isoforms of ERβ in Breast Cancer

Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis

Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1

Screening of Proteins Interacting with p53 by Yeast Two Hybrid System

Human embryo lung cellular protein interacting with severe acute respiratory syndrome

Involvement of Breast Epithelial-Stromal Interactions in the Regulation of Protein Tyrosine Phosphatase-Γ (ptpγ) Mrna Expression by Estrogenically Active Agents

Piwi-Interacting Rnas: A New Class Of Regulator In Human Breast Cancer

Estrogen Receptor Alpha (Er Alpha) Mediates 17 Beta-Estradiol (E2)-Activated Expression Of Hbo1